These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 19722728)
1. Reporting of adverse drug reactions by general practitioners: a questionnaire-based study in the Netherlands. Passier A; ten Napel M; van Grootheest K; van Puijenbroek E Drug Saf; 2009; 32(10):851-8. PubMed ID: 19722728 [TBL] [Abstract][Full Text] [Related]
2. Underreporting in pharmacovigilance: an intervention for Italian GPs (Emilia-Romagna region). Biagi C; Montanaro N; Buccellato E; Roberto G; Vaccheri A; Motola D Eur J Clin Pharmacol; 2013 Feb; 69(2):237-44. PubMed ID: 22706618 [TBL] [Abstract][Full Text] [Related]
3. Attitudinal survey of voluntary reporting of adverse drug reactions. Eland IA; Belton KJ; van Grootheest AC; Meiners AP; Rawlins MD; Stricker BH Br J Clin Pharmacol; 1999 Oct; 48(4):623-7. PubMed ID: 10583035 [TBL] [Abstract][Full Text] [Related]
4. Expectations for feedback in adverse drug reporting by healthcare professionals in the Netherlands. Oosterhuis I; van Hunsel FP; van Puijenbroek EP Drug Saf; 2012 Mar; 35(3):221-32. PubMed ID: 22201474 [TBL] [Abstract][Full Text] [Related]
5. Knowledge, attitude and practice of General Practitioners towards adverse drug reaction reporting in South of Iran, Shiraz (Pharmacoepidemiology report). Peymani P; Tabrizi R; Afifi S; Namazi S; Heydari ST; Shirazi MK; Nouraei H; Sadeghi E; Lankarani KB; Maharlouei N Int J Risk Saf Med; 2016 Mar; 28(1):25-31. PubMed ID: 27176754 [TBL] [Abstract][Full Text] [Related]
6. Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region. Irujo M; Beitia G; Bes-Rastrollo M; Figueiras A; Hernández-Díaz S; Lasheras B Drug Saf; 2007; 30(11):1073-82. PubMed ID: 17973543 [TBL] [Abstract][Full Text] [Related]
7. Knowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in Iran. Vessal G; Mardani Z; Mollai M Pharm World Sci; 2009 Apr; 31(2):183-7. PubMed ID: 19116770 [TBL] [Abstract][Full Text] [Related]
8. Adverse drug reaction reporting by general medical practitioners and retail pharmacists in Harare--a pilot study. Ball D; Tisócki T Cent Afr J Med; 1998 Aug; 44(8):190-5. PubMed ID: 10101417 [TBL] [Abstract][Full Text] [Related]
9. Motives for reporting adverse drug reactions by patient-reporters in the Netherlands. van Hunsel F; van der Welle C; Passier A; van Puijenbroek E; van Grootheest K Eur J Clin Pharmacol; 2010 Nov; 66(11):1143-50. PubMed ID: 20658130 [TBL] [Abstract][Full Text] [Related]
10. Adverse Drug Reaction Monitoring and Reporting Among Physicians and Pharmacists in Pakistan: A Cross-sectional Study. Nisa ZU; Zafar A; Zafar F; Pezaro S; Sher F Curr Drug Saf; 2020; 15(2):137-146. PubMed ID: 32338223 [TBL] [Abstract][Full Text] [Related]
11. The effect of an intervention program on the knowledge and attitudes among medical staff regarding adverse drug reaction reporting. Shchory MP; Goldstein LH; Arcavi L; Shihmanter R; Berkovitch M; Levy A Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1246-1253. PubMed ID: 32316074 [TBL] [Abstract][Full Text] [Related]
12. Adverse drug reaction reporting by nurses in Sweden. Bäckström M; Ekman E; Mjörndal T Eur J Clin Pharmacol; 2007 Jun; 63(6):613-8. PubMed ID: 17404719 [TBL] [Abstract][Full Text] [Related]
13. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India. Tandon VR; Mahajan V; Khajuria V; Gillani Z Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314 [TBL] [Abstract][Full Text] [Related]
14. Pharmacists' attitudes toward adverse drug reaction reporting in Hong Kong. Lee KK; Chan TY; Raymond K; Critchley JA Ann Pharmacother; 1994 Dec; 28(12):1400-3. PubMed ID: 7696734 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys. Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758 [TBL] [Abstract][Full Text] [Related]
16. The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study. Jacobs TG; Hilda Ampadu H; Hoekman J; Dodoo ANO; Mantel-Teeuwisse AK BMC Public Health; 2018 Dec; 18(1):1384. PubMed ID: 30563498 [TBL] [Abstract][Full Text] [Related]
17. Adverse drug reaction reporting by community pharmacists-The barriers and facilitators. Hughes ML; Weiss M Pharmacoepidemiol Drug Saf; 2019 Dec; 28(12):1552-1559. PubMed ID: 31131966 [TBL] [Abstract][Full Text] [Related]
18. Effectiveness of pharmacovigilance training of general practitioners: a retrospective cohort study in the Netherlands comparing two methods. Gerritsen R; Faddegon H; Dijkers F; van Grootheest K; van Puijenbroek E Drug Saf; 2011 Sep; 34(9):755-62. PubMed ID: 21830837 [TBL] [Abstract][Full Text] [Related]
19. How patient reporters identify adverse drug reactions: a qualitative study of reporting via the UK Yellow Card Scheme. Krska J; Anderson C; Murphy E; Avery AJ Drug Saf; 2011 May; 34(5):429-36. PubMed ID: 21513365 [TBL] [Abstract][Full Text] [Related]
20. Are consumers ready to take part in the Pharmacovigilance System?--a Portuguese preliminary study concerning ADR reporting. Matos C; van Hunsel F; Joaquim J Eur J Clin Pharmacol; 2015 Jul; 71(7):883-90. PubMed ID: 26004569 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]